Alkaline Protein Extraction from Fixed Cells

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional cytological tests for detecting oncogenic HPV strains are prone to errors due to contaminants like mucous and blood cells, leading to false results, and existing methods struggle to reliably detect proteins from fixed cells using conventional means, such as ELISA, due to protein precipitation or aggregation caused by certain fixatives.

Innovation Solution

A method involving increasing the pH of fixed cells to at least pH 10.0 and then neutralizing it in the presence of a non-ionic detergent to produce a protein extract suitable for molecular detection assays, allowing for the extraction of proteins that are otherwise insoluble or difficult to detect.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional cytological tests are used to detect oncogenic HPV strains, then the detection process is simple, but the reliability is poor due to contaminants causing false results

Engineering Contradiction:
Improvedetection reliabilityVSAvoidtest complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent extracts and removes contaminants (mucous, blood cells, inflammatory cells) from the cellular sample before performing the detection assay. This extraction step isolates the target HPV proteins from interfering substances, thereby eliminating false positive and false negative results while maintaining a streamlined detection process.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent performs preliminary actions including cell lysis, protein extraction, and contamination removal before the actual detection step. These preliminary steps prepare the sample by removing interfering substances and concentrating target proteins, ensuring accurate detection without requiring complex subsequent processing.

Inventive Principle:
Principle #10Preliminary action

2Stability of the object's composition

If fixatives are used to preserve cells for cytological examination, then the cells remain stable for analysis, but the proteins precipitate or aggregate making them insoluble and difficult to detect

Engineering Contradiction:
Improvecell stabilityVSAvoidprotein detectability
Core Design Contradiction:
Stability of the object's compositionVSDifficulty of detecting and measuring

Solution Approach 1:

The patent changes the chemical parameters of the fixed cell sample by adjusting pH to alkaline conditions (pH 10-11) and using specific buffers during protein extraction. This parameter change dissolves aggregated proteins and restores their solubility, enabling detection while maintaining the fixed state of cells for cytological analysis.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs intermediary reagents including alkaline buffers (Tris, glycine), detergents (Triton X-100, NP-40), and chelating agents (EDTA) that mediate between the fixed cell state and the soluble protein state. These intermediaries facilitate protein solubilization without compromising the fixed morphology of cells, enabling both cytological and molecular analysis.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Ease of operation

If conventional ELISA methods are used to detect proteins from fixed cells, then the detection process is straightforward, but the results are unreliable due to protein precipitation and aggregation

Engineering Contradiction:
Improvedetection easeVSAvoiddetection reliability
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent performs preliminary protein solubilization and deaggregation steps using alkaline buffers and detergents before the ELISA detection. This preliminary action ensures proteins are in a soluble, detectable state, making the subsequent ELISA procedure straightforward and reliable without requiring complex sample preparation during the assay itself.

Inventive Principle:
Principle #10Preliminary action

4Productivity

If contaminants are present in cytological samples, then the sample processing remains simple, but false results occur due to interference with detection

Engineering Contradiction:
Improveprocessing efficiencyVSAvoiddetection accuracy
Core Design Contradiction:
ProductivityVSMeasurement precision

Solution Approach 1:

The patent extracts and removes contaminants (mucous, blood cells, inflammatory cells) through lysis and filtration steps before protein detection. This extraction maintains processing efficiency by using straightforward removal techniques while significantly improving detection accuracy by eliminating interfering substances that cause false results.

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method effectively produces a protein extract that is readily detectable using capture agents, reducing errors and improving the reliability of HPV protein detection, especially for oncogenic strains like HPV 16 and 18, by solubilizing proteins and preventing re-aggregation during neutralization.

Implementation Method 1

contacting the fixed cells with an extraction reagent to produce an intermediate composition having a pH of at least about pH 10.0

Methodology Applied
Scientific EffectAlkaline lysis:

Implementation Method 2

contacting the intermediate composition with a neutralizing reagent to neutralize the pH of the intermediate composition

Methodology Applied
Scientific EffectpH neutralization:

Implementation Method 3

in the presence of a non-ionic detergent, neutralizing the pH of the intermediate composition to produce the protein extract

Methodology Applied
Scientific EffectDetergent action: Surfactant

Data Source

PatentUS9771398B2Method of protein extraction from cells
Publication Date: 2017.09.26 ARBOR VITA CORP

AI summary

Methods for producing a protein extract from cells, such as cells containing viral proteins, are provided. In general terms, the methods involve: increasing the pH of the cells to a pH of at least about pH 10.0 to produce an intermediate composition, and then, in the presence of a non-ionic detergent, neutralizing the pH of the intermediate composition to produce the protein extract. Kits and compositions for practicing the subject methods are also provided.